Consumption of a bioactive compound from Neem plant could significantly suppress development of prostate cancer

Oral administration of nimbolide, over 12 weeks shows reduction of prostate tumor size by up to 70 per cent and decrease in tumor metastasis by up to 50 per cent, report investigators.